LRRC32 and central nervous system cancer: Our data indicate for the first time a key role of the immunoregulatory molecule GARP in the tumor microenvironment of primary brain tumors such as GB and low-grade gliomas inducing and promoting tumor immune tolerance via multiple pathways.